Biologic Use in Pediatric Atopic Dermatitis | Fall Clinical Derm 2025

Atopic dermatitis is increasingly being treated with biologics like dupilumab, but each treatment plan is tailored to the patient’s specific needs, according to Lawrence Eichenfield, M.D., chief of pediatric and adolescent dermatology at Rady Children’s Hospital, San Diego. Biologics can be administered less frequently, and many have longer-term effectiveness, when compared to topical steroids.

“Our next step of the evolution of management is to figure out what families may need,” Eichenfield said during a video interview with Managed Healthcare Executive. “Usually, it’s with an extended course of a biologic if they need it, or advanced systemic therapy to make sure you get that life impact of changing the disease significantly.”

Eichenfield will speak at the 2025 Fall Clinical Dermatology Conference, held in Las Vegas, Nevada, from Oct. 23 to 26. He will present his session, ‘Pediatric Dermatology - Who Has Better Pearls?’ on Oct. 25.